Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karan Kumar

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Journal of Molecular Graphics & Modelling|December 21, 2022
Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor - An in-silico analysisSamridhi Johri, Banoth Karan Kumar, Sanchita Dey, et al.
Chemosphere|July 21, 2024
Diet characteristics of tidal creek-associated fishes of the northeastern Arabian Sea with special reference to microplastic ingestionAbhijit Mallik, Puja Chakraborty, Karan Kumar Ramteke, et al.
RSC Advances|April 7, 2025
Unraveling PPARβ/δ nuclear receptor agonists <i>via</i> a drug-repurposing approach: HTVS-based ligand identification, molecular dynamics, pharmacokinetics, and <i>in vitro</i> anti-steatotic validationSumit Kumar Mandal, Mohammed Muzaffar-Ur-Rehman, Sonakshi Puri, et al.
Molecular Diversity|June 6, 2023
Targeting lipid-sensing nuclear receptors PPAR (α, γ, β/δ): HTVS and molecular docking/dynamics analysis of pharmacological ligands as potential pan-PPAR agonistsSumit Kumar Mandal, Sonakshi Puri, Banoth Karan Kumar, et al.
Bioorganic Chemistry|April 3, 2021
Design, synthesis and biological evaluation of 7-(5-((substituted - amino)-methyl)-thiophen-2-yl)-spiro-[chroman-2,4'-piperidin]-4-one hydrochloride analogues as anticancer agentsSurendar Chitti, Sravani Pulya, Adinarayana Nandikolla, et al.
Journal of Clinical and Experimental Hepatology|April 17, 2026
Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the DrugKaran Kumar, Vivek Saraswat, Ashish Kumar, et al.
Annals of Medicine and Surgery (2012)|June 23, 2022
Plasma random glucose levels at hospital admission predicting worse outcomes in STEMI patients undergoing PCI: A case seriesTooba Ahmed Kirmani, Manjeet Singh, Sumeet Kumar, et al.
Bioorganic Chemistry|September 18, 2020
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, et al.
Seminars in Liver Disease|June 7, 2022
Early Diagnosis and Prevention of Infections in CirrhosisAnand V Kulkarni, Madhumita Premkumar, Juan P Arab, et al.
Future Medicinal Chemistry|January 5, 2022
Design, synthesis and structure-activity relationship studies of novel spirochromanone hydrochloride analogs as anticancer agentsSurendar Chitti, Sravani Pulya, Adinarayana Nandikolla, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Journal of Molecular Graphics & Modelling|December 21, 2022
Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor - An in-silico analysisSamridhi Johri, Banoth Karan Kumar, Sanchita Dey, et al.
Chemosphere|July 21, 2024
Diet characteristics of tidal creek-associated fishes of the northeastern Arabian Sea with special reference to microplastic ingestionAbhijit Mallik, Puja Chakraborty, Karan Kumar Ramteke, et al.
RSC Advances|April 7, 2025
Unraveling PPARβ/δ nuclear receptor agonists <i>via</i> a drug-repurposing approach: HTVS-based ligand identification, molecular dynamics, pharmacokinetics, and <i>in vitro</i> anti-steatotic validationSumit Kumar Mandal, Mohammed Muzaffar-Ur-Rehman, Sonakshi Puri, et al.
Molecular Diversity|June 6, 2023
Targeting lipid-sensing nuclear receptors PPAR (α, γ, β/δ): HTVS and molecular docking/dynamics analysis of pharmacological ligands as potential pan-PPAR agonistsSumit Kumar Mandal, Sonakshi Puri, Banoth Karan Kumar, et al.
Bioorganic Chemistry|April 3, 2021
Design, synthesis and biological evaluation of 7-(5-((substituted - amino)-methyl)-thiophen-2-yl)-spiro-[chroman-2,4'-piperidin]-4-one hydrochloride analogues as anticancer agentsSurendar Chitti, Sravani Pulya, Adinarayana Nandikolla, et al.
Journal of Clinical and Experimental Hepatology|April 17, 2026
Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the DrugKaran Kumar, Vivek Saraswat, Ashish Kumar, et al.
Annals of Medicine and Surgery (2012)|June 23, 2022
Plasma random glucose levels at hospital admission predicting worse outcomes in STEMI patients undergoing PCI: A case seriesTooba Ahmed Kirmani, Manjeet Singh, Sumeet Kumar, et al.
Bioorganic Chemistry|September 18, 2020
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, et al.
Seminars in Liver Disease|June 7, 2022
Early Diagnosis and Prevention of Infections in CirrhosisAnand V Kulkarni, Madhumita Premkumar, Juan P Arab, et al.
Future Medicinal Chemistry|January 5, 2022
Design, synthesis and structure-activity relationship studies of novel spirochromanone hydrochloride analogs as anticancer agentsSurendar Chitti, Sravani Pulya, Adinarayana Nandikolla, et al.
Pageof 14